• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨髓移植后的免疫恢复

Immune recovery after bone marrow transplantation.

作者信息

Lum L G

机构信息

Department of Medicine, Wayne State University, Detroit, Michigan.

出版信息

Hematol Oncol Clin North Am. 1990 Jun;4(3):659-75.

PMID:2193017
Abstract

The donor-derived immune system that forms after bone marrow transplantation (BMT) takes as long as 2 years to develop in healthy BMT recipients. Soon after BMT, GVHD and its treatment increase the susceptibility of the recipient to overwhelming infections, and they retard the development of the immune system. The new system develops from a primitive state characterized by cytotoxic and suppressive functions and progresses to a mature state characterized by the development of specialized lymphocyte functions such as lymphokine production, proliferation, and expression of growth factor receptors. These specialized functions develop in healthy long-term recipients, whereas the same functions may be absent or impaired in those who develop chronic GVHD.

摘要

骨髓移植(BMT)后形成的供体来源免疫系统在健康的BMT受者中需要长达2年的时间才能发育成熟。BMT后不久,移植物抗宿主病(GVHD)及其治疗会增加受者对严重感染的易感性,并阻碍免疫系统的发育。新系统从以细胞毒性和抑制功能为特征的原始状态发展而来,逐渐进展到以淋巴因子产生、增殖和生长因子受体表达等专门淋巴细胞功能的发展为特征的成熟状态。这些专门功能在健康的长期受者中得以发展,而在发生慢性GVHD的患者中,这些相同的功能可能会缺失或受损。

相似文献

1
Immune recovery after bone marrow transplantation.骨髓移植后的免疫恢复
Hematol Oncol Clin North Am. 1990 Jun;4(3):659-75.
2
Pretransplant tumor antigen-specific immunization of allogeneic bone marrow transplant donors enhances graft-versus-tumor activity without exacerbation of graft-versus-host disease.对异基因骨髓移植供体进行移植前肿瘤抗原特异性免疫可增强移植物抗肿瘤活性,而不会加重移植物抗宿主病。
Cancer Res. 2000 Oct 15;60(20):5797-802.
3
CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.来自基因分型 HLA 不相同的相关供体的 CD6+ T 细胞耗竭的异基因骨髓移植。
Biol Blood Marrow Transplant. 1997 Apr;3(1):11-7.
4
Alloreactivity and the predictive value of anti-recipient specific interleukin 2 producing helper T lymphocyte precursor frequencies for alloreactivity after bone marrow transplantation.异基因反应性以及抗受体特异性产生白细胞介素2的辅助性T淋巴细胞前体细胞频率对骨髓移植后异基因反应性的预测价值。
Dan Med Bull. 2002 May;49(2):89-108.
5
Immunological recovery after bone marrow transplantation: role of age, graft-versus-host disease, prednisolone treatment and infections.
Bone Marrow Transplant. 1987 Feb;1(3):317-28.
6
The putative role of HLA-C recognition in graft versus host disease (GVHD) and graft rejection after unrelated bone marrow transplantation (BMT).人类白细胞抗原C(HLA-C)识别在无关供体骨髓移植(BMT)后移植物抗宿主病(GVHD)和移植物排斥反应中的假定作用。
Exp Hematol. 1995 Dec;23(14):1667-75.
7
Amotosalen-treated donor T cells have polyclonal antigen-specific long-term function without graft-versus-host disease after allogeneic bone marrow transplantation.经氨甲蝶呤处理的供体T细胞在异基因骨髓移植后具有多克隆抗原特异性长期功能且无移植物抗宿主病。
Biol Blood Marrow Transplant. 2005 Mar;11(3):169-80. doi: 10.1016/j.bbmt.2004.12.332.
8
Long-term observation after simultaneous lung and intra-bone marrow-bone marrow transplantation.肺与骨髓腔内骨髓联合移植后的长期观察
J Heart Lung Transplant. 2005 Sep;24(9):1415-23. doi: 10.1016/j.healun.2004.08.015.
9
Anti-IL-4 antibody prevents graft-versus-host disease in mice after bone marrow transplantation. The IgE allotype is an important marker of graft-versus-host disease.抗白细胞介素-4抗体可预防小鼠骨髓移植后的移植物抗宿主病。免疫球蛋白E同种异型是移植物抗宿主病的重要标志物。
J Immunol. 1995 Mar 15;154(6):2687-96.
10
Chimerism and tolerance: from freemartin cattle and neonatal mice to humans.嵌合体与免疫耐受:从弗里马丁牛和新生小鼠到人类
Hum Immunol. 1997 Feb;52(2):155-61. doi: 10.1016/S0198-8859(96)00290-X.

引用本文的文献

1
Epidemiology of infections in cancer patients.癌症患者感染的流行病学
Cancer Treat Res. 2014;161:43-89. doi: 10.1007/978-3-319-04220-6_2.
2
Poor immune reconstitution after four or five major HLA antigens mismatched T cell-depleted allogeneic and autologous stem cell transplantation.在四或五个主要人类白细胞抗原(HLA)抗原不匹配且去除T细胞的异基因和自体干细胞移植后免疫重建不良。
Clin Exp Immunol. 2001 Jan;123(1):162-9. doi: 10.1046/j.1365-2249.2001.01429.x.
3
Long-term persistence of oligoclonal serum IgM repertoires in patients treated with allogeneic bone marrow transplantation (BMT).
接受异基因骨髓移植(BMT)治疗的患者中寡克隆血清IgM库的长期持续性。
Clin Exp Immunol. 2000 Jan;119(1):240-9. doi: 10.1046/j.1365-2249.2000.01118.x.
4
Infection in the bone marrow transplant recipient and role of the microbiology laboratory in clinical transplantation.骨髓移植受者的感染及微生物学实验室在临床移植中的作用。
Clin Microbiol Rev. 1997 Apr;10(2):277-97. doi: 10.1128/CMR.10.2.277.
5
Immunologic and hematopoietic effects of CD40 stimulation after syngeneic bone marrow transplantation in mice.同基因骨髓移植后小鼠体内CD40刺激的免疫和造血效应
J Clin Invest. 1997 Feb 1;99(3):484-91. doi: 10.1172/JCI119183.
6
Differential recovery of polymorphonuclear neutrophils, B and T cell subpopulations in the thymus, bone marrow, spleen and blood of mice following split-dose polychemotherapy.分次剂量联合化疗后小鼠胸腺、骨髓、脾脏和血液中多形核中性粒细胞、B和T细胞亚群的差异恢复情况
Cancer Immunol Immunother. 1994 Jul;39(1):59-67. doi: 10.1007/BF01517182.
7
T cell receptor repertoire of CD4+ and CD8+ T cell subsets in the allogeneic bone marrow transplant recipient.异基因骨髓移植受者中CD4+和CD8+ T细胞亚群的T细胞受体库
Cancer Immunol Immunother. 1995 Aug;41(2):104-10. doi: 10.1007/BF01527406.